Serum triglyceride concentration in dogs with epilepsy treated with phenobarbital or with phenobarbital and bromide.
D000818:Animals; D001965:Bromides / Q000009:adverse effects* / Q000627:therapeutic use; D016022:Case-Control Studies; D003430:Cross-Sectional Studies; D004283:Dog Diseases / Q000097:blood* / Q000188:drug therapy; D004285:Dogs; D004827:Epilepsy / Q000097:blood / Q000188:drug therapy / Q000662:veterinary*; D005215:Fasting / Q000097:blood; D005260:Female; D015228:Hypertriglyceridemia / Q000097:blood / Q000209:etiology / Q000662:veterinary; D008297:Male; D010195:Pancreatitis / Q000097:blood / Q000209:etiology / Q000662:veterinary; D010634:Phenobarbital / Q000009:adverse effects* / Q000627:therapeutic use; D017680:Potassium Compounds / Q000009:adverse effects* / Q000627:therapeutic use; D012307:Risk Factors; D014280:Triglycerides / Q000097:blood*
D001965:Bromides; D017680:Potassium Compounds; D014280:Triglycerides; C039004:potassium bromide; D010634:Phenobarbital